Skip to Content

Nedocromil Pregnancy and Breastfeeding Warnings

Nedocromil is also known as: Tilade

Nedocromil Pregnancy Warnings

Nedocromil has been assigned to pregnancy category B by the FDA. Animal studies using doses of 100 mg/kg/day subcutaneously have not revealed evidence of adverse fetal outcome. There are no controlled data in human pregnancy. Nedocromil is only recommended for use during pregnancy when benefit outweighs risk.

See references

Nedocromil Breastfeeding Warnings

There are no data on the excretion of nedocromil into human milk. The manufacturer recommends that caution be used when administering nedocromil to nursing women,

See references

References for pregnancy information

  1. Mcdonald CF, Burdon JGW "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust 165 (1996): 485-8
  2. "Product Information. Tilade (nedocromil)." Rhone-Poulenc Rorer, Collegeville, PA.
  3. Dombrowski MP "Pharmacologic therapy of asthma during pregnancy." Obstet Gynecol Clin North Am 24 (1997): 559

References for breastfeeding information

  1. Mcdonald CF, Burdon JGW "Asthma in pregnancy and lactation - a position paper for the thoracic society of australia and new zealand." Med J Aust 165 (1996): 485-8
  2. "Product Information. Tilade (nedocromil)." Rhone-Poulenc Rorer, Collegeville, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide